Repro Med Systems Performance
The company holds a Beta of 0.0, which implies not very significant fluctuations relative to the market. the returns on MARKET and Repro Med are completely uncorrelated.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Repro Med Systems has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Repro Med is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors. ...more
| Fifty Two Week Low | 1.3500 | |
| Target High Price | 5.50 | |
| Fifty Two Week High | 4.2600 | |
| Target Low Price | 4.50 |
Repro |
Repro Med Relative Risk vs. Return Landscape
If you would invest (100.00) in Repro Med Systems on January 17, 2024 and sell it today you would earn a total of 100.00 from holding Repro Med Systems or generate -100.0% return on investment over 90 days. Repro Med Systems is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of otc stocks are less volatile than Repro, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Repro Med Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Repro Med's investment risk. Standard deviation is the most common way to measure market volatility of otc stocks, such as Repro Med Systems, and traders can use it to determine the average amount a Repro Med's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| REPR |
Based on monthly moving average Repro Med is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Repro Med by adding Repro Med to a well-diversified portfolio.
Repro Med Fundamentals Growth
Repro OTC Stock prices reflect investors' perceptions of the future prospects and financial health of Repro Med, and Repro Med fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Repro OTC Stock performance.
| Return On Equity | 0.27 | |||
| Return On Asset | 10.67 | |||
| Profit Margin | 0.13 % | |||
| Operating Margin | 9.81 % | |||
| Current Valuation | 131.75 M | |||
| Shares Outstanding | 38.38 M | |||
| Price To Earning | 393.75 X | |||
| Price To Book | 16.13 X | |||
| Price To Sales | 8.02 X | |||
| Revenue | 19.14 M | |||
| EBITDA | 2.21 M | |||
| Cash And Equivalents | 3.81 M | |||
| Cash Per Share | 0.10 X | |||
| Total Debt | 444.08 K | |||
| Debt To Equity | 4.60 % | |||
| Book Value Per Share | 0.25 X | |||
| Cash Flow From Operations | (960.03 K) | |||
| Total Asset | 8.34 M | |||
| Retained Earnings | 3.02 M | |||
| Current Asset | 7.01 M | |||
| Current Liabilities | 1.41 M |
Things to note about Repro Med Systems performance evaluation
Checking the ongoing alerts about Repro Med for important developments is a great way to find new opportunities for your next move. OTC Stock alerts and notifications screener for Repro Med Systems help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Repro Med Systems is not yet fully synchronised with the market data | |
| Repro Med Systems has some characteristics of a very speculative penny stock | |
| Repro Med Systems has a very high chance of going through financial distress in the upcoming years | |
| Repro Med Systems currently holds about 3.81 M in cash with (960.03 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.1. | |
| Roughly 44.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Repro Med's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Repro Med's stock is overvalued or undervalued compared to its peers.
- Examining Repro Med's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Repro Med's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Repro Med's management team can help you assess the OTC Stock's leadership.
- Pay attention to analyst opinions and ratings of Repro Med's otc stock. These opinions can provide insight into Repro Med's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Consideration for investing in Repro OTC Stock
If you are still planning to invest in Repro Med Systems check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Repro Med's history and understand the potential risks before investing.
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |